SingHealth Duke-NUS Launches Allergic Diseases Centre to Streamline Care for One in Four Singaporeans

The new SingHealth Duke-NUS Allergic Diseases Centre integrates care for asthma, eczema, and food allergies to lower costs and improve patient outcomes.

By: AXL Media

Published: Apr 17, 2026, 10:03 AM EDT

Source: Information for this report was sourced from The Straits Times

A Unified Front Against the Rising Tide of Hypersensitivity

The healthcare landscape in Singapore saw a significant evolution on April 17 with the formal launch of the SingHealth Duke-NUS Allergic Diseases Centre (SDADC). Introduced during the 26th SGH Annual Scientific Meeting, the facility is designed to dismantle the silos that traditionally separate allergy treatments. Associate Professor Lee Haur Yueh, the center’s director, emphasized that because allergic conditions rarely manifest in isolation, the medical community must transition toward a coordinated, patient-centered model. This strategic move targets the increasing complexity of immune responses that affect a large segment of the local population.

Bridging the Gap Between Pediatric and Adult Clinical Care

One of the primary structural benefits of the new center is the creation of a seamless transition for patients moving from youth to adulthood. Senior Minister of State for Health Tan Kiat How noted that a child receiving treatment for severe eczema at KK Women’s and Children’s Hospital can now migrate to adult services at Singapore General Hospital without the usual administrative or clinical friction. This integrated approach ensures that patients with multi-system allergies, which might involve rheumatology or respiratory medicine, no longer have to navigate a fragmented network of specialists at different locations, thereby reducing resource duplication.

Leveraging Smart Data to Track Lifelong Immune Trends

Beyond clinical consultation, the SDADC is set to function as a sophisticated data hub for immunological research. The center will develop a dedicated allergy database powered by advanced analytics to monitor high-risk individuals and track long-term treatment efficacy. According to Associate Professor Lee, this repository will be instrumental in understanding why some adults suddenly develop new allergies while others outgrow them. By utilizing this smart data, clinicians hope to identify markers for success in various therapies and ensure that historical patient information remains accessible throughout a resident's life.